Generic Name: gilteritinib (GIL te RI ti nib)
Brand Name: Xospata
What is gilteritinib?
Gilteritinib is used to treat acute myeloid leukemia (AML) in adults with an abnormal FLT3 gene. Your doctor will test you for this gene.
gilteritinib is used when AML has come back or has not improved with prior treatment.
Gilteritinib may also be used for purposes not listed in this medication guide.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
You should not use gilteritinib if you are allergic to it.
Tell your doctor if you have ever had:
long QT syndrome (in you or a family member); or
an electrolyte imbalance (such as low levels of potassium or magnesium in your blood).
Before you take gilteritinib, your heart function may need to be checked using an electrocardiograph or ECG (sometimes called an EKG).
Gilteritinib can harm an unborn baby or cause birth defects if the mother or the father is using this medicine.
If you are a woman, do not use gilteritinib if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.
If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using gilteritinib.
Do not breast-feed while using this medicine, and for at least 2 months after your last dose.
How should I take gilteritinib?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Gilteritinib is usually given once per day. Take this medicine with a full glass of water, at the same time each day.
You may take gilteritinib with or without food.
Do not crush, chew, or break a gilteritinib tablet. Swallow it whole.
It may take several months before you receive the full benefit of taking gilteritinib. Your doctor will determine how long to treat you with this medicine.
Do not change your dose or stop taking gilteritinib without your doctor's advice.
Store this medicine in the original container at room temperature, away from moisture and heat.
What happens if I miss a dose?
Take the missed dose on the same day you remember it. Skip the missed dose if your next dose is due in less than 12 hours. Do not use two doses within a 12-hour period.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking gilteritinib?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Gilteritinib side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
headache, confusion, change in mental status, vision loss, seizure (convulsions);
fever, chills, cough with mucus, chest pain;
flu symptoms, mouth and throat ulcers;
severe pain in your upper stomach spreading to your back, nausea and vomiting;
a light-headed feeling, like you might pass out; or
fast or pounding heartbeats, fluttering in your chest, shortness of breath, and sudden dizziness (like you might pass out).
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects may include:
cough, shortness of breath;
muscle or joint pain;
abnormal liver function tests.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Gilteritinib dosing information
Usual Adult Dose for Acute Myeloid Leukemia:
120 mg orally once a day until disease progression or unacceptable toxicity
-Response may be delayed. In the absence of disease progression or unacceptable toxicity, patients should be treated for a minimum of 6 months to allow time for a clinical response.
-Select patients for the treatment of AML with this drug based on the presence of FLT3 mutations in the blood or bone marrow.
Use: For the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.
What other drugs will affect gilteritinib?
Other drugs may affect gilteritinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2018 Cerner Multum, Inc. Version: 1.01.
More about gilteritinib
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: multikinase inhibitors
Other brands: Xospata